Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

Brief Report: Pain and Post-Traumatic Stress Disorder Screening Outcomes Among Military Personnel Injured During Combat Deployment.

Image of 03_Pain and PTSD. U.S. Air Force Airman 1st Class Miranda Lugo, right, 18th Operational Medical Readiness Squadron mental health technician and Guardian Wingman trainer, and Maj. Joanna Ho, left, 18th OMRS director of psychological health, discuss the suicide prevention training program, Guardian Wingman, at Kadena Air Base, Japan, Aug. 20, 2021. Guardian Wingman aims to promote wingman culture and early help-seeking behavior. (U.S. Air Force photo by Airman 1st Class Anna Nolte)

Background

The post-9/11 U.S. military conflicts in Iraq and Afghanistan lasted over a decade and yielded the most combat casualties since the Vietnam War.1 While patient survivability increased to the high­est level in history, a changing epidemiology of combat injuries emerged whereby focus shifted to addressing an array of long-term sequelae, including physical, psychologi­cal, and neurological issues.2,3 The long-term effects of combat injury can adversely impact well-being and exact a significant burden on the health care system.4–6
Physical pain is common among mili­tary personnel returning from deployment, particularly those injured in combat,7–9 and is associated with detrimental effects such as medical discharge10 and sub­stance use disorders.11 Pain has also been linked to post-traumatic stress disorder (PTSD), which is common in veterans of the Iraq and Afghanistan conflicts.12 The mutual maintenance model posits that PTSD symptoms may exacerbate chronic pain and, in turn, pain may contribute to or enhance existing PTSD symptoms.13 PTSD is associated with negative outcomes among veterans with chronic pain, includ­ing disability, decreased functioning, and sleep disturbances,14 making the study of pain and PTSD essential for improved patient care and rehabilitation. 
Previous research on the co-occur­rence of pain and PTSD in wounded ser­vice members has been limited by small sample sizes, specific injuries, or short follow-up periods.15–17 The present study adds to the existing literature by examin­ing the association between pain and PTSD screening outcomes nearly a decade after combat injury among a large, national sam­ple of service members and veterans who were injured during deployment and expe­rienced a wide range of injuries.

Methods

Data were collected from the Wounded Warrior Recovery Project (WWRP).4 Par­ticipants are identified from the Expedition­ary Medical Encounter Database (EMED), a deployment health repository maintained by the Naval Health Research Center that includes clinical records of service mem­bers injured in overseas contingency oper­ations since 2001.18 Individuals whose data are in the EMED are approached via postal mail and email to provide informed con­sent for participation in the WWRP and to complete biannual assessments of patient-reported outcomes for 15 years. Enrollment is conducted on a rolling basis, and data collection is ongoing. 

The present study utilized cross-sec­tional data from the seventh wave of the WWRP (i.e., 36 months post-baseline survey), when participants were asked to report on their pain during the past 6 months using the Chronic Pain Grading Scale.19 The measure was introduced into the WWRP in 2015 and was asked of all participants only at the seventh wave. Stan­dardized scoring procedures were used to calculate (1) pain intensity (a composite variable derived from current pain, worst pain in the past 6 months, and average pain in the past 6 months), (2) frequency of pain interference (number of days in the past 6 months that the respondent has been kept from their usual activities such as work, school, or housework because of pain), and (3) level of pain interference (a composite variable of how much pain has interfered with daily activities; recreational, social, and family activities; and ability to work, including housework).
PTSD screening status was measured using the PTSD Checklist–Civilian ver­sion (PCL-C) and PTSD Checklist for the DSM-5 (PCL-5). Both versions of the PCL are comparable in military personnel and veterans.20 WWRP measures and proce­dures were updated in late 2018 to remain consistent with current standards of mea­surement of PTSD symptoms. Scores were summed for each PCL-related measure. Standard cutoffs of 44 and 33 indicated positive screens for PTSD using the PCL-C and PCL-5, respectively.21,22 

Data from 2,649 combat-injured ser­vice members and veterans who partici­pated in the WWRP between 1 December 2015 and 30 September 2021 were included in the analysis. Injury date, Injury Sever­ity Scores (ISS), and demographics were obtained from the EMED. The ISS is a scor­ing system that accounts for multiple inju­ries in a patient and provides an overall measure of injury severity that ranges from 0 (no injury) to 75 (fatal injury). ISS was categorized as mild (1–3), moderate (4–8), and serious/severe (ISS 9+). Indepen­dent sample t-tests were used to examine mean differences in pain variables by PTSD screening status. An alpha level of .05 was considered statistically significant. Analy­ses were performed using SPSS Statistics, version 25 (IBM Corp., Armonk, NY).

Results

Participants were mostly enlisted, non-Hispanic White males in the Army (Table). At the time of the WWRP assess­ment, mean age was 37.2 years (standard deviation [SD]=7.6) and average time since injury was 9.4 years (SD=3.7). A majority of participants (86.9%) were injured in a blast and over one-half (54.1%) sustained mild injuries overall. Injury severity was not associated with PTSD screening sta­tus (p=.212). Participants who screened positive for PTSD had higher average pain intensity (60.6 vs. 37.5, p<.001, d=1.10), days of pain interference (42.7 vs. 9.8, p<.001, d=0.80), and level of pain interfer­ence (50.7 vs. 20.3, p<.001, d=1.29) than those who screened negative.

Editorial Comment

This study describes a significant association between PTSD screening out­comes and pain following combat injury. These results are consistent with previous literature and reaffirm that psychological and physical health issues can overlap and potentially complicate patient manage­ment.3 In a report by Shipherd et al.,23 66% of veterans who sought treatment for PTSD had comorbid chronic pain. Another study found that diagnosis of PTSD yielded 5 times greater odds of persistent pain com­plaints,24 and other research suggests a link between greater pain severity after combat injury and PTSD risk.25 Further, the poly­trauma clinical triad (co-occurrence of concussion, pain, and PTSD) was found in 42% of military polytrauma patients.8 Sharp and Harvey13 highlighted several possible pathways whereby pain and PTSD could be mutually maintaining, including pain acting as a reminder of the trauma, reduced activity levels, and increased pain perception due to elevated anxiety. Nota­bly, injury severity in the present study was not associated with PTSD screening sta­tus. This finding is consistent with previ­ous research17 and can be explained by ISS being a measure of mortality risk, which may not be directly related to other out­comes, such as mental health. Future stud­ies are needed to elucidate the etiological pathways of comorbid pain and PTSD after combat injury. Because pain and PTSD can co-occur many years after injury, the early recog­nition and identification of these condi­tions in primary care settings and through periodical health assessments may be important to refine clinical practice and, ultimately, improve the overall public health of the military.

Furthermore, the use of multidisciplinary health care teams should be examined and considered for use in future military conflicts to address co-occurring physical and psychological issues, which negatively impact long-term quality of life.3 A similar model was suc­cessfully employed to increase return-to-duty rates following concussion and could be adapted to address other injuries.26 Such interventions should be considered for veterans in long-term care and also during the early phase following combat injury, as recent research demonstrated that symptom complaints in the initial year post-injury predicted mental and physical health years later.27 

This analysis has several limitations that should be considered when interpret­ing the results. A key limitation is due to the cross-sectional design of this study; because PTSD and pain were measured at a single point in time, their temporal­ity could not be assessed. Elucidating this relationship could be useful in developing targeted intervention and treatment strat­egies. Further, measures were obtained on average 9 years after injury, and other factors unaccounted for in the present study (e.g., depression, sleep problems, concussion) may influence the relation­ship between pain and PTSD. Additional research is needed to examine this relation­ship over time and include an assessment of confounders. Nevertheless, the findings suggest that pain is associated with PTSD years after injury and could inform medi­cal providers involved in the treatment and rehabilitation of military personnel after combat injury.

Author Affiliations

Naval Health Research Center, San Diego, CA (Dr. Mac­Gregor, Dr. Jurick, Dr. McCabe, Dr. Harb­ertson, Ms. Dougherty, and Mr. Galarneau); Leidos, Inc., San Diego, CA (Dr. Jurick, Dr. McCabe, Dr. Harbertson, Ms. Dougherty); Axiom Resource Management, Inc., San Diego, CA (Dr. MacGregor).

Disclaimer

The authors are military service members or employees of the U.S. Government. This work was prepared as part of their official duties. Title 17, U.S.C. §105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. §101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that per­son’s official duties. Report No. 22-19 was supported by the U.S. Navy Bureau of Medi­cine and Surgery under work unit no. 60808. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Depart­ment of the Navy, Department of Defense, nor the U.S. Government. The study protocol was approved by the Naval Health Research Center Institutional Review Board in com­pliance with all applicable Federal regula­tions governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center Institutional Review Board protocol, number NHRC.2009.0014.

References

  1. Goldberg MS. Casualty rates of US military personnel during the wars in Iraq and Afghanistan. Defence Peace Econ. 2018;29(1):44–61.
  2. Cannon JW, Holena DN, Geng Z, et al. Com­prehensive analysis of combat casualty outcomes in U.S. service members from the beginning of World War II to the end of Operation Enduring Free­dom. J Trauma Acute Care Surg. 2020;89(suppl 2):S8–S15.
  3. MacGregor AJ, Zouris JM, Watrous JR, et al. Multimorbidity and quality of life after blast-relat­ed injury among US military personnel: a cluster analysis of retrospective data. BMC Public Health. 2020;20(1):578.
  4. Watrous JR, Dougherty AL, McCabe CT, Sack DI, Galarneau MR. The Wounded Warrior Recov­ery Project: a longitudinal examination of patient-reported outcomes among deployment-injured military personnel. Mil Med. 2019;184(3-4):84–89.
  5. Dalton MK, Jarman MP, Manful A, Koehlmoos TP, Cooper Z, Weissman JS, Schoenfeld AJ. The hidden costs of war: healthcare utilization among individuals sustaining combat-related trauma (2007–2018). Ann Surg. Published online ahead of print (2 March 2021). 
  6. Geiling J, Rosen JM, Edwards RD. Medical costs of war in 2035: long-term care challenges for veterans of Iraq and Afghanistan. Mil Med. 2012;177(11):1235–1244.
  7. Wilkie R. Fighting pain and addiction for veter­ans. October 26, 2018. https://trumpwhitehouse.archives.gov/articles/fighting-pain-addiction-veter­
    ans/. Accessed March 4, 2022.  
  8. Lew HL, Otis JD, Tun C, Kerns RD, Clark ME, Cifu DX. Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clini­cal triad. J Rehabil Res Dev. 2009;46(6):697-702.
  9. Mazzone B, Farrokhi S, Hendershot BD, Mc­Cabe CT, Watrous JR. Prevalence of low back pain and relationship to mental health symptoms and quality of life after a deployment-related lower limb amputation. Spine. 2020;45(19):1368–1375.
  10. Benedict TM, Singleton MD, Nitz AJ, Shing TL, Kardouni JR. Effect of chronic low back pain and post-traumatic stress disorder on the risk for separation from the US Army. Mil Med. 2019;184(9-10):431–439.
  11. Dembek ZF, Chekol T, Wu A. The opioid epi­demic: challenge to military medicine and national security. Mil Med. 2020;185(5-6):e662–e667.
  12. Peterson AL. General perspective on the U.S. military conflicts in Iraq and Afghanistan after 20 years. Mil Med. 2021.
  13. Sharp TJ, Harvey AG. Chronic pain and post­traumatic stress disorder: mutual maintenance? Clin Psychol Rev. 2001;21(6):857–877.
  14. Benedict TM, Keenan PG, Nitz AJ, Moeller-Bertram T. Post-traumatic stress disorder symp­toms contribute to worse pain and health outcomes in veterans with PTSD compared to those without: a systematic review with meta-analysis. Mil Med. 2020;185(9-10):e1481–e1491.
  15. Giordano NA, Richmond TS, Farrar JT, Buck­enmaier III CC, Gallagher RM, Polomano RC. Dif­ferential pain presentations observed across post-traumatic stress disorder symptom trajectories after combat injury. Pain Med. 2021;22(11):2638–2647.
  16. Castillo R, Carlini AR, Doukas WC, et al. Ex­tremity trauma among United State military serving in Iraq and Afghanistan: Results from the Military Extremity Trauma and Amputation/Limb Salvage Study. J Ortho Trauma. 2021;35(3)e96–e102.
  17. Soumoff AA, Clark NG, Spinks EA, et al. So­matic symptom severity, not injury severity predicts probable posttraumatic stress disorder and major depressive disorder in wounded service members. J Trauma Stress. 2021;35(1):210–221.
  18. Galarneau MR, Hancock WC, Konoske P, et al. The Navy-Marine Corps Combat Trauma Registry. Mil Med. 2006;171(8):691–697.
  19. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–149.
  20. LeardMann CA, McMaster HS, Warner S, et al. Comparison of posttraumatic stress disorder checklist instruments from Diagnostic and Sta­tistical Manual of Mental Disorders, fourth edition vs fifth edition in a large cohort of US military ser­vice members and veterans. JAMA Netw Open. 2021;4(4):e218072.
  21. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N Engl J Med. 2008;358(5):453–463.
  22. Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489–498.
  23. Shipherd JC, Keyes M, Jovanovic T, et al. Vet­erans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? J Re­habil Res Dev. 2007;44(2):153–166.
  24. Higgins DM, Kerns RD, Brandt CA, et al. Persistent pain and comorbidity among Op­eration Enduring Freedom/Operation Iraqi Free­dom/Operation New Dawn veterans. Pain Med. 2014;15(5):782–790.
  25. Giordano NA, Bader C, Richmond TS, Polo­mano RC. Complexity of the relationships of pain, posttraumatic stress, and depression in combat-injured populations: an integrative review to inform evidence-based practice. Worldviews Evid Based Nurs. 2018;15(2):113–126.
  26. Spooner SP, Tyner SD, Sowers C, Tsao J, Stuessi K. Utility of a sports medicine model in mili­tary combat concussion and musculoskeletal res­toration care. Mil Med. 2014;179(11):1319–1324.
  27. MacGregor AJ, Dougherty AL, D’Souza EW, et al. Symptom profiles following combat injury and long-term quality of life: a latent class analysis. Qual Life Res. 2021;30(9):2531–2540.

Characteristics of the study population and pain items by post-traumatic stress disorder (PTSD) screening status

You also may be interested in...

Vasectomy and Vasectomy Reversals, Active Component, U.S. Armed Forces, 2000–2017

Article
3/1/2019
Sperm is the male reproductive cell  Photo: iStock

During 2000–2017, a total of 170,878 active component service members underwent a first-occurring vasectomy, for a crude overall incidence rate of 8.6 cases per 1,000 person-years (p-yrs). Among the men who underwent incident vasectomy, 2.2% had another vasectomy performed during the surveillance period. Compared to their respective counterparts, the overall rates of vasectomy were highest among service men aged 30–39 years, non-Hispanic whites, married men, and those in pilot/air crew occupations. Male Air Force members had the highest overall incidence of vasectomy and men in the Marine Corps, the lowest. Crude annual vasectomy rates among service men increased slightly between 2000 and 2017. The largest increases in rates over the 18-year period occurred among service men aged 35–49 years and among men working as pilots/air crew. Among those who underwent vasectomy, 1.8% also had at least 1 vasectomy reversal during the surveillance period. The likelihood of vasectomy reversal decreased with advancing age. Non-Hispanic black and Hispanic service men were more likely than those of other race/ethnicity groups to undergo vasectomy reversals.

Testosterone Replacement Therapy Use Among Active Component Service Men, 2017

Article
3/1/2019
Testosterone

This analysis summarizes the prevalence of testosterone replacement therapy (TRT) during 2017 among active component service men by demographic and military characteristics. This analysis also determines the percentage of those receiving TRT in 2017 who had an indication for receiving TRT using the 2018 American Urological Association (AUA) clinical practice guidelines. In 2017, 5,093 of 1,076,633 active component service men filled a prescription for TRT, for a period prevalence of 4.7 per 1,000 male service members. After adjustment for covariates, the prevalence of TRT use remained highest among Army members, senior enlisted members, warrant officers, non-Hispanic whites, American Indians/Alaska Natives, those in combat arms occupations, healthcare workers, those who were married, and those with other/unknown marital status. Among active component male service members who received TRT in 2017, only 44.5% met the 2018 AUA clinical practice guidelines for receiving TRT.

Update: Malaria, U.S. Armed Forces, 2018

Article
2/1/2019
Anopheles merus

Malaria infection remains an important health threat to U.S. service mem­bers who are located in endemic areas because of long-term duty assign­ments, participation in shorter-term contingency operations, or personal travel. In 2018, a total of 58 service members were diagnosed with or reported to have malaria. This represents a 65.7% increase from the 35 cases identi­fied in 2017. The relatively low numbers of cases during 2012–2018 mainly reflect decreases in cases acquired in Afghanistan, a reduction due largely to the progressive withdrawal of U.S. forces from that country. The percentage of cases of malaria caused by unspecified agents (63.8%; n=37) in 2018 was the highest during any given year of the surveillance period. The percent­age of cases identified as having been caused by Plasmodium vivax (10.3%; n=6) in 2018 was the lowest observed during the 10-year surveillance period. The percentage of malaria cases attributed to P. falciparum (25.9 %) in 2018 was similar to that observed in 2017 (25.7%), although the number of cases increased. Malaria was diagnosed at or reported from 31 different medical facilities in the U.S., Afghanistan, Italy, Germany, Djibouti, and Korea. Pro­viders of medical care to military members should be knowledgeable of and vigilant for clinical manifestations of malaria outside of endemic areas.

Update: Incidence of Glaucoma Diagnoses, Active Component, U.S. Armed Forces, 2013–2017

Article
2/1/2019
Glaucoma

Glaucoma is an eye disease that involves progressive optic nerve damage and vision loss, leading to blindness if undetected or untreated. This report describes an analysis using the Defense Medical Surveillance System to identify all active component service members with an incident diagnosis of glaucoma during the period between 2013 and 2017. The analysis identified 37,718 incident cases of glaucoma and an overall incidence rate of 5.9 cases per 1,000 person-years (p-yrs). The majority of cases (97.6%) were diagnosed at an early stage as borderline glaucoma; of these borderline cases, 2.2% progressed to open-angle glaucoma during the study period. No incident cases of absolute glaucoma, or total blindness, were identified. Rates of glaucoma were higher among non-Hispanic black (11.0 per 1,000 p-yrs), Asian/Pacific Islander (9.5), and Hispanic (6.9) service members, compared with non-Hispanic white (4.0) service members. Rates among female service members (6.6 per 1,000 p-yrs) were higher than those among male service members (5.8). Between 2013 and 2017, incidence rates of glaucoma diagnoses increased by 75.4% among all service members.

Re-evaluation of the MSMR Case Definition for Incident Cases of Malaria

Article
2/1/2019
Anopheles merus

The MSMR has been publishing the results of surveillance studies of malaria since 1995. The standard MSMR case definition uses Medical Event Reports and records of hospitalizations in counting cases of malaria. This report summarizes the performance of the standard MSMR case definition in estimating incident cases of malaria from 2015 through 2017. Also explored was the potential surveillance value of including outpatient encounters with diagnoses of malaria or positive laboratory tests for malaria in the case definition. The study corroborated the relative accuracy of the MSMR case definition in estimating malaria incidence and provided the basis for updating the case definition in 2019 to include positive laboratory tests for malaria antigen within 30 days of an outpatient diagnosis.

Outbreak of Acute Respiratory Illness Associated with Adenovirus Type 4 at the U.S. Naval Academy, 2016

Article
2/1/2019
Malaria case definition

Human adenoviruses (HAdVs) are known to cause respiratory illness outbreaks at basic military training (BMT) sites. HAdV type-4 and -7 vaccines are routinely administered at enlisted BMT sites, but not at military academies. During Aug.–Sept. 2016, U.S. Naval Academy clinical staff noted an increase in students presenting with acute respiratory illness (ARI). An investigation was conducted to determine the extent and cause of the outbreak. During 22 Aug.–11 Sept. 2016, 652 clinic visits for ARI were identified using electronic health records. HAdV-4 was confirmed by real-time polymerase chain reaction assay in 18 out of 33 patient specimens collected and 1 additional HAdV case was detected from hospital records. Two HAdV-4 positive patients were treated for pneumonia including 1 hospitalized patient. Molecular analysis of 4 HAdV-4 isolates identified genome type 4a1, which is considered vaccine-preventable. Understanding the impact of HAdV in congregate settings other than enlisted BMT sites is necessary to inform discussions regarding future HAdV vaccine strategy.

Thyroid Disorders, Active Component, U.S. Armed Forces, 2008–2017

Article
12/1/2018
Cover 1

This analysis describes the incidence and prevalence of five thyroid disorders (goiter, thyrotoxicosis, primary/not otherwise specified [NOS] hypothyroidism, thyroiditis, and other disorders of the thyroid) among active component service members between 2008 and 2017. During the 10-year surveillance period, the most common incident thyroid disorder among male and female service members was primary/NOS hypothyroidism and the least common were thyroiditis and other disorders of thyroid. Primary/NOS hypothyroidism was diagnosed among 8,641 females (incidence rate: 43.7 per 10,000 person-years [p-yrs]) and 11,656 males (incidence rate: 10.2 per 10,000 p-yrs). Overall incidence rates of all thyroid disorders were 3 to 5 times higher among females compared to males. Among both males and females, incidence of primary/NOS hypothyroidism was higher among non-Hispanic white service members compared with service members in other race/ethnicity groups. The incidence of most thyroid disorders remained stable or decreased during the surveillance period. Overall, the prevalence of most thyroid disorders increased during the first part of the surveillance period and then either decreased or leveled off.31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Adrenal Gland Disorders, Active Component, U.S. Armed Forces, 2002–2017

Article
12/1/2018
Adrenal Gland Disorders, Active Component, U.S. Armed Forces, 2002–2017

During 2002–2017, the most common incident adrenal gland disorder among male and female service members was adrenal insufficiency and the least common was adrenomedullary hyperfunction. Adrenal insufficiency was diagnosed among 267 females (crude overall incidence rate: 8.2 cases per 100,000 person-years [p-yrs]) and 729 males (3.9 per 100,000 p-yrs). In both sexes, overall rates of other disorders of adrenal gland and Cushing’s syndrome were lower than for adrenal insufficiency but higher than for hyperaldosteronism, adrenogenital disorders, and adrenomedullary hyperfunction. Crude overall rates of adrenal gland disorders among females tended to be higher than those of males, with female:male rate ratios ranging from 2.1 for adrenal insufficiency to 5.5 for androgenital disorders and Cushing’s syndrome. The highest overall rates of adrenal insufficiency for males and females were among non-Hispanic white service members. Among females, rates of Cushing's syndrome and other disorders of adrenal gland were 31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Incidence and Prevalence of the Metabolic Syndrome Using ICD-9 and ICD-10 Diagnostic Codes, Active Component, U.S. Armed Forces, 2002–2017

Article
12/1/2018
Incidence and Prevalence of the Metabolic Syndrome Using ICD-9 and ICD-10 Diagnostic Codes, Active Component, U.S. Armed Forces, 2002–2017

This report uses ICD-9 and ICD-10 codes (277.7 and E88.81, respectively) for the metabolic syndrome (MetS) to summarize trends in the incidence and prevalence of this condition among active component members of the U.S. Armed Forces between 2002 and 2017. During this period, the crude overall incidence rate of MetS was 7.5 cases per 100,000 person-years (p-yrs). Compared to their respective counterparts, overall incidence rates were highest among Asian/Pacific Islanders, Air Force members, and warrant officers and were lowest among those of other/unknown race/ethnicity, Marine Corps members, and junior enlisted personnel and officers. During 2002–2017, the annual incidence rates of MetS peaked in 2009 at 11.6 cases per 100,000 p-yrs and decreased to 5.9 cases per 100,000 p-yrs in 2017. Annual prevalence rates of MetS increased steadily during the first 11 years of the surveillance period reaching a high of 38.9 per 100,000 active component service members in 2012, after which rates declined slightly to 31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Page 14 of 14 , showing items 196 - 204
First < ... 11 12 13 14 > Last 
Refine your search
Last Updated: November 01, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery